Skip to main content
Clinical Trials/NCT05078554
NCT05078554CompletedNot Applicable

HPV Vaccination (Human Papilloma Virus), or How to Address Male Homosexuality in General Practice in Alsace?

University Hospital, Strasbourg, France1 site in 1 country15 target enrollmentStarted: May 27, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
15
Locations
1
Primary Endpoint
Retrospective descriptive study of vaccination against HPV (Human Papilloma Virus) in Alsace?

Study Overview

Brief Summary

The main objective of this study is to find out whether young MSM (men who have sex with men) believe it is important for their GP to be informed of their sexual orientation, in order to improve their clinical, especially with HPV vaccination.

The secondary objective is to analyze the state of knowledge about the HPV vaccine and the value of HPV vaccine in this target population.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 26 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Retrospective descriptive study of vaccination against HPV (Human Papilloma Virus) in Alsace?

Time Frame: Files analysed retrospectively from April 27, 2021 to January 27, 2020 will be examined]

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Strasbourg, France
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials